All companies

Rigid Metal & Glass

Chongqing Zhengchuan

Broader sector Shanghai Stock Exchange: 603976
Headquarters
Chongqing, CN
Segment
Rigid Metal & Glass
Stories held
1
Last story
28 Sep 2026

Chongqing Zhengchuan Pharmaceutical Packaging makes tubular glass vials, ampoules, pre-filled syringes, cartridges and screw vials for the pharmaceutical industry, founded in 1988 and based in Chongqing, China. The company states annual capacity of more than 10 billion glass vials and is listed on the Shanghai Stock Exchange.

1 stories · 2026

China's Linuo Pharmaceutical Packaging files for Hong Kong listing

Shandong Linuo Pharmaceutical Packaging, listed on Shenzhen's ChiNext since November 2021, filed on 28 September 2026 for a main-board listing on the Hong Kong Stock Exchange, with China Merchants Securities International and Lego Financial Group as joint sponsors. The borosilicate glass maker ranks ninth in China's pharmaceutical glass packaging market and first in China, second globally, in daily-use heat-resistant glass. Proceeds are earmarked for industrialising semiconductor packaging glass substrates and RTU and PFS production.

Why this mattersA dual listing would give a leading Chinese borosilicate glass packaging player fresh capital to scale semiconductor glass substrates, a potential new growth line adjacent to pharma packaging.

  • Filed for Hong Kong main-board listing on 28 September 2026, already listed on Shenzhen ChiNext since 11 November 2021
  • Ranked 9th in China's pharmaceutical glass packaging market with 2.4% share by 2025 revenue, per Frost & Sullivan
  • Ranked 1st in China and 2nd globally in daily-use heat-resistant glass, with 9.5% domestic and 5.1% global market share
  • 2025 revenue was USD 146.4m (RMB 981.5m), down from USD 161.2m (RMB 1,080.8m) in 2024
  • 2025 net profit was USD 5.9m (RMB 39.7m), down from USD 9.9m (RMB 66.1m) in 2024
  • IPO proceeds earmarked for industrialising semiconductor packaging glass substrates and RTU and PFS production plus R&D
  • Adjusted net profit for H1 2026 rose 11.9% to USD 6.8m (RMB 45.837m), even as reported net profit fell 23.9% to USD 4.7m (RMB 31.157m).
Gerresheimer mentioned Schott AG mentioned Linuo Packaging Shandong Pharmaceutical Glass mentioned Chongqing Zhengchuan mentioned
Relevant to you?